A study of mutations in Beta-catenin and APC genes in PTC, FTC and benign thyroid tumors suggested that mutations in these genes are rare and that the activation of the Wnt signaling pathway may not contribute to pathogenesis in human PTC and FTC [31]. Here, CTNNB1 is linked to benign thyroid gland neoplasm.